Page last updated: 2024-10-31

metoclopramide and Hepatic Veno Occlusive Disease

metoclopramide has been researched along with Hepatic Veno Occlusive Disease in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Research Excerpts

ExcerptRelevanceReference
"Busulfan was quantitated in plasma samples at 10 time points within the 6 h dosing interval using HPLC before and after dose numbers 1, 2, 5, 13 and 14."1.29Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted? ( Blanz, J; Ehninger, G; Kühnle, A; Kumbier, I; Mewes, K; Proksch, B; Schroer, S; Schuler, U; Zeller, KP, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schuler, U1
Schroer, S1
Kühnle, A1
Blanz, J1
Mewes, K1
Kumbier, I1
Proksch, B1
Zeller, KP1
Ehninger, G1

Other Studies

1 other study available for metoclopramide and Hepatic Veno Occlusive Disease

ArticleYear
Busulfan pharmacokinetics in bone marrow transplant patients: is drug monitoring warranted?
    Bone marrow transplantation, 1994, Volume: 14, Issue:5

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Drug Monitoring; Eating; Female; He

1994